Press Releases
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018
Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
Recro Pharma Announces PDUFA Date for IV Meloxicam
Recro Announces Expansion of CDMO Service Capabilities
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018
Recro Pharma Provides Regulatory Update for IV Meloxicam
